In contrast to our results that suggest that high MCOLN2 mRNA expression may be associated with better biochemical relapse-free survival outcomes, another study implied a worse overall survival of prostate cancers with high MCOLN2 mRNA [45]. This evidence concerns the gene MCOLN2 and Familial prostate cancer.